Ad hoc announcement pursuant to Article 53 of the SIX listing rules
Kuros Biosciences increases the annual guidance for 2025, The company reports 77% year-over-year increase for the first nine months of 2025
Seeking Alpha / 25 minutes from now 2 Views
Comments